Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




A Randomized, Multicenter, Open-Label Study of Poly-L-Lactic Acid for HIV-1 Facial Lipoatrophy
Link ID 2856
Title A Randomized, Multicenter, Open-Label Study of Poly-L-Lactic Acid for HIV-1 Facial Lipoatrophy
Url http://www.medscape.com/viewprogram/8666?src=rss
Description Poly-L-lactic acid injections may be able to improve facial lipoatrophy among patients with HIV infection, but the efficacy of this treatment is yet to be firmly established. The current randomized trial examines the efficacy and safety of poly-L-lactic acid injections for facial lipoatrophy. JAIDS: Journal of Acquired Immune Deficiency Syndrome
Category Articles > Cardiology
Keywords
Date Feb 1, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Cardiology
1. Managing Type 2 Diabetes: Developing Office-based Systems of Care
  Through case discussion, examine the pathophysiology of diabetes, review pharmacologic therapies, address cardiovascular risk reduction, and identify management strategies for the busy office practice.
Category:   Articles > Cardiology


2. What Your Patients Are Reading: Oral Contraceptives Provide Long-Term Protection Against Ovarian Can
  Studies show that oral contraceptives may protect against ovarian cancer, a Western diet may increase risk for metabolic syndrome, insurance copayments may deter women from getting mammograms, cold medicines can be dangerous to young children, 2 stents for treating myocardial infarction may be equivalent, and gastric banding may lead to remission of type 2 diabetes. Medscape Medical News
Category:   Articles > Cardiology


3. BRIEF-PCI: Infusion of Eptifibatide Can Be Shortened
  A shortened, two-hour infusion of the GP IIb/IIIa inhibitor eptifibatide following nonemergency PCI is just as effective as the standard 18-hour infusion of the drug and is probably safer, according to a new study. Heartwire
Category:   Articles > Cardiology


4. FDA Renews Caution Against Mixing Simvastatin >20 mg/day and Amiodarone
  Patients who take more than 20 mg/day of simvastatin in addition to amiodarone are at increased risk for rhabdomyolysis, the Food and Drug Administration has reminded physicians in the US. Medscape Medical News
Category:   Articles > Cardiology


5. Metabolic Syndrome: Another Nail in the Coffin?
  The metabolic syndrome is not linked with cardiovascular risk in the elderly and that a fasting plasma glucose test is as good a predictor of diabetes as the syndrome. Medscape Medical News
Category:   Articles > Cardiology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS